Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update
Sue Wilson, Kirstie N. Anderson, David S. Baldwin, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 8, pp. 923-947
Open Access | Times Cited: 241

Showing 1-25 of 241 citing articles:

Sleep disturbance and psychiatric disorders
Daniel Freeman, Bryony Sheaves, Felicity Waite, et al.
The Lancet Psychiatry (2020) Vol. 7, Iss. 7, pp. 628-637
Closed Access | Times Cited: 505
Circadian rhythm as a therapeutic target
Wei Ruan, Xiaoyi Yuan, Holger K. Eltzschig
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 4, pp. 287-307
Open Access | Times Cited: 293
Sleep and anxiety: From mechanisms to interventions
Sarah L. Chellappa, Daniel Aeschbach
Sleep Medicine Reviews (2021) Vol. 61, pp. 101583-101583
Closed Access | Times Cited: 261
Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Franco De Crescenzo, Gian Loreto D’Alò, Edoardo G. Ostinelli, et al.
The Lancet (2022) Vol. 400, Iss. 10347, pp. 170-184
Open Access | Times Cited: 241
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
Dieter Riemann, Colin A. Espie, Ellemarije Altena, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 216
Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
Jack D. Edinger, J. Todd Arnedt, Suzanne M. Bertisch, et al.
Journal of Clinical Sleep Medicine (2020) Vol. 17, Iss. 2, pp. 263-298
Open Access | Times Cited: 204
The European Academy for Cognitive Behavioural Therapy for Insomnia: An initiative of the European Insomnia Network to promote implementation and dissemination of treatment
Chiara Baglioni, Ellemarije Altena, Bjørn Bjorvatn, et al.
Journal of Sleep Research (2019) Vol. 29, Iss. 2
Open Access | Times Cited: 202
Insomnia disorder: State of the science and challenges for the future
Dieter Riemann, Fee Benz, Raphael J. Dressle, et al.
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Open Access | Times Cited: 191
Insomnia
Michael L. Perlis, Donn Posner, Dieter Riemann, et al.
The Lancet (2022) Vol. 400, Iss. 10357, pp. 1047-1060
Closed Access | Times Cited: 185
Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis
Elisabeth Hertenstein, Ersilia Trinca, Marina Wunderlin, et al.
Sleep Medicine Reviews (2022) Vol. 62, pp. 101597-101597
Open Access | Times Cited: 180
Co-Morbid Insomnia and Sleep Apnea (COMISA): Prevalence, Consequences, Methodological Considerations, and Recent Randomized Controlled Trials
Alexander Sweetman, Leon Lack, Célyne Bastien
Brain Sciences (2019) Vol. 9, Iss. 12, pp. 371-371
Open Access | Times Cited: 168
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
Emmanuel Mignot, David Mayleben, Ingo Fietze, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 2, pp. 125-139
Closed Access | Times Cited: 145
Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis
Zainab Alimoradi, Elahe Jafari, Anders Broström, et al.
Sleep Medicine Reviews (2022) Vol. 64, pp. 101646-101646
Open Access | Times Cited: 80
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Sleep and schizophrenia: From epiphenomenon to treatable causal target
Felicity Waite, Bryony Sheaves, Louise Isham, et al.
Schizophrenia Research (2019) Vol. 221, pp. 44-56
Open Access | Times Cited: 113
Telemedicine versus face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled noninferiority trial
J. Todd Arnedt, Deirdre A. Conroy, Ann Mooney, et al.
SLEEP (2020) Vol. 44, Iss. 1
Open Access | Times Cited: 89
Biological rhythms and chronotherapeutics in depression
Pierre A. Geoffroy, Laura Palagini
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110158-110158
Open Access | Times Cited: 83
Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps
Fabio Ferrarelli
American Journal of Psychiatry (2021) Vol. 178, Iss. 10, pp. 903-913
Open Access | Times Cited: 75
Insomnia and menopause: a narrative review on mechanisms and treatments
Paola Proserpio, Stefano Marra, Chiara Campana, et al.
Climacteric (2020) Vol. 23, Iss. 6, pp. 539-549
Closed Access | Times Cited: 73
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Clemens Muehlan, Cédric Vaillant, Isabelle Zenklusen, et al.
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1063-1078
Closed Access | Times Cited: 70
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
Dieter Kunz, Yves Dauvilliers, Heike Beneš, et al.
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 93-106
Open Access | Times Cited: 52
Comparative efficacy and acceptability of cognitive behavioral therapy delivery formats for insomnia in adults: A systematic review and network meta-analysis
Ya Gao, Long Ge, Ming Liu, et al.
Sleep Medicine Reviews (2022) Vol. 64, pp. 101648-101648
Closed Access | Times Cited: 49
Long-term use of benzodiazepines in chronic insomnia: a European perspective
Michael Soyka, Imane Wild, Bérangère Caulet, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 32
Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson’s Disease
Xinyu Hu, Jingwen Li, Xinyi Wang, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 396-396
Open Access | Times Cited: 28
Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review
Jaden Brandt, Jolene Bressi, Mê‐Linh Lê, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102507-102507
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top